Could GLP-1 drugs be anti-aging medications?

Key Points:

• GLP-1 medications, used for weight loss and diabetes, show potential to slow biological aging by improving various health markers and reducing risks of age-related diseases, though research is still in early stages.
• A clinical trial with tirzepatide indicated a slowing of biological aging by about 0.7 to 1.1 years over 72 weeks in overweight adults, but the study lacked a placebo group and had a short follow-up period.
• Novo Nordisk's semaglutide demonstrated reductions in biological age of multiple organs by one to four years, with effects not fully explained by weight loss or blood sugar control, suggesting broader systemic benefits.
• Mouse studies showed semaglutide extended lifespan and improved cognitive and metabolic functions beyond what was achieved by calorie restriction alone, indicating benefits beyond weight loss.
• Experts caution that it is too early to use GLP-1 drugs solely for anti-aging purposes, especially in healthy, non-obese individuals, and emphasize the need for longer-term studies to confirm these findings.